mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.1 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.074 |
0.2 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.076 |
0.2 |